Z-value: 1.028
Transcription factors associated with Nfat5:
Activity-expression correlation:
View svg image
View png image
Showing 1 to 20 of 78 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 43 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
0.0 |
7.7 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
0.9 |
7.0 |
GO:0032264 |
IMP salvage(GO:0032264) |
0.2 |
6.7 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 |
6.0 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
1.9 |
5.7 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 |
5.1 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
1.4 |
4.3 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.2 |
4.3 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
1.1 |
4.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 |
4.2 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
0.6 |
4.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 |
3.8 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
0.3 |
3.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
1.0 |
3.0 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 |
3.0 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
0.2 |
2.7 |
GO:0030575 |
nuclear body organization(GO:0030575) |
0.2 |
2.6 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
0.0 |
2.5 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
0.3 |
2.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
0.7 |
2.1 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 22 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
0.1 |
6.0 |
GO:0005811 |
lipid particle(GO:0005811) |
0.0 |
5.5 |
GO:0005743 |
mitochondrial inner membrane(GO:0005743) |
0.4 |
4.3 |
GO:0044327 |
dendritic spine membrane(GO:0032591) dendritic spine head(GO:0044327) |
0.2 |
4.2 |
GO:0044300 |
cerebellar mossy fiber(GO:0044300) |
0.3 |
4.1 |
GO:0031143 |
pseudopodium(GO:0031143) |
0.2 |
3.8 |
GO:0045334 |
clathrin-coated endocytic vesicle(GO:0045334) |
0.0 |
3.0 |
GO:0031594 |
neuromuscular junction(GO:0031594) |
0.0 |
3.0 |
GO:0032587 |
ruffle membrane(GO:0032587) |
0.0 |
2.8 |
GO:0031225 |
anchored component of membrane(GO:0031225) |
0.3 |
2.7 |
GO:0042382 |
paraspeckles(GO:0042382) |
0.0 |
2.3 |
GO:0030315 |
T-tubule(GO:0030315) |
0.0 |
2.2 |
GO:0005923 |
bicellular tight junction(GO:0005923) |
0.1 |
1.5 |
GO:0030061 |
mitochondrial crista(GO:0030061) |
0.0 |
1.4 |
GO:0005814 |
centriole(GO:0005814) |
0.0 |
1.2 |
GO:0030992 |
intraciliary transport particle B(GO:0030992) |
0.1 |
1.0 |
GO:0012510 |
trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 |
1.0 |
GO:0005849 |
mRNA cleavage factor complex(GO:0005849) |
0.1 |
0.8 |
GO:0048787 |
presynaptic active zone membrane(GO:0048787) |
0.0 |
0.5 |
GO:0008385 |
IkappaB kinase complex(GO:0008385) |
0.0 |
0.5 |
GO:0005852 |
eukaryotic translation initiation factor 3 complex(GO:0005852) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 34 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
0.4 |
7.7 |
GO:0003841 |
1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.0 |
7.0 |
GO:0003876 |
AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 |
6.0 |
GO:0004303 |
estradiol 17-beta-dehydrogenase activity(GO:0004303) |
1.9 |
5.7 |
GO:0004145 |
diamine N-acetyltransferase activity(GO:0004145) |
0.7 |
5.6 |
GO:0042609 |
CD4 receptor binding(GO:0042609) |
0.0 |
5.3 |
GO:0015293 |
symporter activity(GO:0015293) |
0.8 |
4.8 |
GO:0030284 |
estrogen receptor activity(GO:0030284) |
0.0 |
4.3 |
GO:0017137 |
Rab GTPase binding(GO:0017137) |
0.5 |
4.2 |
GO:0043423 |
3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 |
4.2 |
GO:0001106 |
RNA polymerase II transcription corepressor activity(GO:0001106) |
1.4 |
4.1 |
GO:0031896 |
V2 vasopressin receptor binding(GO:0031896) |
1.0 |
3.8 |
GO:0004784 |
superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 |
3.8 |
GO:0031419 |
cobalamin binding(GO:0031419) |
0.0 |
3.0 |
GO:0008013 |
beta-catenin binding(GO:0008013) |
0.0 |
3.0 |
GO:0061630 |
ubiquitin protein ligase activity(GO:0061630) |
0.6 |
2.6 |
GO:0086038 |
calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 |
2.1 |
GO:0008131 |
primary amine oxidase activity(GO:0008131) |
0.5 |
1.9 |
GO:0034714 |
type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 |
1.7 |
GO:0034711 |
inhibin binding(GO:0034711) |
0.2 |
1.5 |
GO:0008499 |
UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |